| |
| | 8-(Substituted N-phenylcarboxamidomethyl) pyrrolizidines and use thereof as antiarrhythmics - Patent 4564624 |
 | | The compounds of this invention are used as a therapeutic agent for arrhythmia in the form of free base or in a form of pharmacologically acceptable salt, for instance, hydrochloride, which can be administered orally or non-orally singly or together with conventional harmless excipients in a suitable composition form such as capsule, tablet or injection. |
 | | Effective dose of an antiarrhythmic agent varies depending on administration method, types and degrees of arrhythmic and physical conditions of patients, but, in general, it should be an amount sufficient for causing dysrhythmia to normalize. |
 | | In the case of a compound of this invention, a practical dosage is, when administered orally, 50-200 mg/day/adult, and this dosage is divided into 3-4 times, and, when administered by intravenous drip injection, 0.5-5 mg/kg (body weight) is used. |
| www.freepatentsonline.com /4564624.html (1189 words) |
|